Bialer Meir | Department Of Pharmaceutics And David R. Bloom Center For Pharmacy School Of Pharmacy Faculty Of Med
スポンサーリンク
概要
- BIALER Meirの詳細を見る
- 同名の論文著者
- Department Of Pharmaceutics And David R. Bloom Center For Pharmacy School Of Pharmacy Faculty Of Medの論文著者
関連著者
-
Bialer Meir
Department Of Pharmaceutics And David R. Bloom Center For Pharmacy School Of Pharmacy Faculty Of Med
-
BIALER Meir
Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerus
-
Yagen Boris
Department Of Natural Products And Medicinal Chemistry School Of Pharmacy Faculty Of Medicine Hebrew
-
Bialer Meir
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine Hebrew University Of Jerusalem
-
Bialer Meir
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine Hebrew University Fo Jerusalem
-
Yagen Boris
Department Of Medicinal Chemistry And Natural Products Hebrew University Of Jerusalem
-
Bialer Meir
The David R. Bloom Center For Pharmacy
-
Yagen Boris
Departments Of Natural Products And Medicinal Chemistry School Of Pharmacy Faculty Of Medicine The H
-
ISOHERRANEN Nina
Departments of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jeru
-
Isoherranen Nina
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine Hebrew University Of Jerusalem
-
Isoherranen Nina
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine Hebrew University Fo Jerusalem
-
Spiegelstein Ofer
Center For Environmental And Genetic Medicine Texas A&m University
-
DOOSE Dennis
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
-
Finnell Richard
Center For Environmental And Genetic Medicine Texas A&m University
-
Roeder Michael
Institute Of Organic Chemistry University Of Tubingen
-
Woodhead Jose
Anticonvulsant Drug Development Program Department Of Pharmacology And Toxicology University Of Utah
-
Doose Dennis
Johnson & Johnson Pharmaceutical Research & Development L. L. C.
-
WHITE H.
Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Ut
-
FINNELL Richard
Institute of Biosciences and Technology, Texas A&M University
-
SCHWABE Stefan
Johnson & Johnson Pharmaceutical Research & Development L. L. C.
-
SCHURIG Volker
Institute of Organic Chemistry, University of Tubingen
-
SPIEGELSTEIN Ofer
Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerus
-
Schwabe Stefan
Johnson & Johnson Pharmaceutical Research & Development L. L. C.
-
Schurig Volker
Institute Of Organic Chemistry University Of Tubingen
-
Schurig Volker
Institut Fur Organische Chemie Universitat Tubingen
-
Finnell Richard
Institute Of Biosciences And Technology Texas A&m University System Health Science Center
-
White H.
Anticonvulsant Drug Development Program Department Of Pharmacology And Toxicology University Of Utah
-
CHADWICK David
Walton Centre for Neurology & Neurosurgery, University of Liverpool
-
Britzi Malka
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine The Hebrew University Of Jerusale
-
Zhang Jing
Institute Of Antibiotics Huashan Hospital Fudan University
-
Levy Rene
Department Of Pharmaceutics School Of Pharmacy University Of Washington
-
Chadwick David
Walton Hospital Clinical Trials Unit
-
MIMROD Dorit
Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerus
-
SPECCHIO Luigi
Clinic of Nervous System Diseases, University of Foggia
-
PERUCCA Emilio
Institute of Neurology IRCCS C. Mondino Foundation, and Clinical Pharmacology Unit, Department of In
-
SPECCHIO Nicola
Epilepsy Center, Department of Neurological and Psychiatric Sciences, University of Bari
-
LA NEVE
Epilepsy Center, Department of Neurological and Psychiatric Sciences, University of Bari
-
SOBACK Stefan
National Residue Control Laboratory, Kimron Veterinary Institute
-
MARYANOFF Bruce
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
-
La Neve
Epilepsy Center Department Of Neurological And Psychiatric Sciences University Of Bari
-
Steinman Amir
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine Hebrew University Of Jerusalem
-
Bialer Meir
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine The Hebrew University Of Jerusale
-
Bialer Meir
Department Of Pharmaceutics Hebrew University Of Jerusalem
-
Bialer Meir
Department Of Pharmaceutics And David R. Bloom Centre For Pharmacy School Of Pharmacy Faculty Of Med
-
Mimrod Dorit
Department Of Pharmaceutics School Of Pharmacy Faculty Of Medicine The Hebrew University Of Jerusale
-
Doose Dennis
Johnson & Johnson Pharmaceutical Research & Development L.l.c.
-
Soback Stefan
National Residue Control Laboratory Kimron Veterinary Institute
-
Soback Stefan
Kimron Veterinary Institute National Residue Control Laboratory
-
Specchio Luigi
Clinic Of Nervous System Diseases University Of Foggia
-
Gatti Giuliana
Clinical Pharmacology Unit Department Of Internal Medicine And Therapeutics University Of Pavia
-
BENNETT Gregory
Department of Neurosurgery
-
Brodie Martin
Western Infirmary Epilepsy Unit
-
Bennett Gregory
Department Of Cell Biology And Anatomy University Of Nebraska Medical Center
-
WILCOX Karen
Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Ut
-
BARTON Matthew
Anticonvulsant Drug Development Program, Department of Pharmacology and Toxicology, University of Ut
-
FINNELL Richard
Center for Environmental and Genetic Medicine, Texas A&M University
-
Specchio Nicola
Epilepsy Center Department Of Neurological And Psychiatric Sciences University Of Bari
-
Maryanoff Bruce
Johnson & Johnson Pharmaceutical Research & Development L.l.c.
-
WILSON Elaine
Western Infirmary, Epilepsy Unit
-
OXBURY John
Radcliffe Infirmary
-
BERRY David
Medical Toxicology Unit
-
BIALER Meir
School of Pharmacy and David R. Bloom Center for Pharmacy, Faculty of Medicine, The Hebrew Universit
-
WANG Shean-Sheng
Johnson & Johnson Pharmaceutical Research & Development, L. L. C.
-
PADMANABHAN Mukund
Johnson & Johnson Pharmaceutical Research & Development, L. L. C.
-
JACOBS David
Johnson & Johnson Pharmaceutical Research & Development, L. L. C.
-
SPIEGELSTEIN Ofer
Institute of Biosciences and Technology, Texas A&M University System Health Science Center
-
MERRIWEATHER Michelle
Institute of Biosciences and Technology, Texas A&M University System Health Science Center
-
TRIPLETT Aleata
Center for Human Molecular Genetics, University of Nebraska Medical Center
-
Jacobs David
Johnson & Johnson Pharmaceutical Research & Development L. L. C.
-
Padmanabhan Mukund
Johnson & Johnson Pharmaceutical Research & Development L. L. C.
-
EYAL Sara
Department of Pharmaceutics, Hebrew University of Jerusalem
-
SOBOL Eyal
Department of Pharmaceutics, Hebrew University of Jerusalem
-
ALTSCHULER Yoram
Department of Pharmacology, School of Pharmacy, Faculty of Medicine, Ein Karem, Hebrew University of
-
SHMUEL Miriam
Department of Pharmacology, School of Pharmacy, Faculty of Medicine, Ein Karem, Hebrew University of
-
Wilson Elaine
Western Infirmary Epilepsy Unit
-
Perucca Emilio
Institute Of Neurology Irccs C. Mondino Foundation And Clinical Pharmacology Unit Department Of Inte
-
Wang Shean-sheng
Johnson & Johnson Pharmaceutical Research & Development L. L. C.
-
Eyal Sara
Department Of Pharmaceutics Hebrew University Of Jerusalem
-
Sobol Eyal
Department Of Pharmaceutics Hebrew University Of Jerusalem
-
Wilcox Karen
Anticonvulsant Drug Development Program Department Of Pharmacology And Toxicology University Of Utah
-
Shmuel Miriam
Department Of Pharmacology School Of Pharmacy Faculty Of Medicine Ein Karem Hebrew University Of Jer
-
Barton Matthew
Anticonvulsant Drug Development Program Department Of Pharmacology And Toxicology University Of Utah
-
Spiegelstein Ofer
Institute Of Biosciences And Technology Texas A&m University System Health Science Center
-
Triplett Aleata
Center For Human Molecular Genetics University Of Nebraska Medical Center
-
Altschuler Yoram
Department Of Pharmacology School Of Pharmacy Faculty Of Medicine Ein Karem Hebrew University Of Jer
-
Merriweather Michelle
Institute Of Biosciences And Technology Texas A&m University System Health Science Center
-
YACOBI Avi
Taro Pharmaceuticals
-
MOROS Daniel
Department of Neurology, Mount Sinai Medical School
-
LEVITT Barrie
Department of Medicine, Albert Einstein Medical School
-
HOULE Jean-Marie
L. A. B. Bio-Research International
-
MUNSAKA Melvin
L. A. B. Bio-Research International
-
Moros Daniel
Department Of Neurology Mount Sinai Medical School
-
Levitt Barrie
Department Of Medicine Albert Einstein Medical School
-
Zhang Jing
Institute Of Biosciences And Technology Texas A&m University System Health Science Center
著作論文
- A Comparative Study of the Effect of Carbamazepine and Valproic Acid on the Pharmacokinetics and Metabolic Profile of Topiramate at Steady State in Patients with Epilepsy
- Anticonvulsant Profile and Teratogenicity of N-methyl-tetramethylcyclopropyl Carboxamide : A New Antiepileptic Drug
- Gas chromatographic determination of novel valproyl taurinamide derivatives in mouse and dog plasma
- Topiramate and Lamotrigine Pharmacokinetics during Repetitive Monotherapy and Combination Therapy in Epilepsy Patients
- Effect of Topiramate or Carbamazepine on the Pharmacokinetics of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol in Healthy Obese and Nonobese Female Subjects
- Developmental Outcome of Levetiracetam, Its Major Metabolite in Humans, 2-Pyrrolidinone N-Butyric Acid, and Its Enantiomer (R)-α-ethyl-oxo-pyrrolidine Acetamide in a Mouse Model of Teratogenicity
- Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection
- Structure-Pharmacokinetic-Pharmacodynamic Relationships of N-Alkyl Derivatives of the New Antiepileptic Drug Valproyl Glycinamide
- Isolation of N,N-dialkylated derivatives of valproylglycinamide from dog plasma by active charcoal adsorption and their quantification by high-performance liquid chromatography
- Anticonvulsant Profile of Valrocemide (TV1901) : A New Antiepilptic Drug
- The Activity of Antiepileptic Drugs as Histone Deacetylase Inhibitors
- Criteria to Assess In Vivo Performance and Bioequivalence of Generic Controlled-Release Formulations of Carbamazepine